Exercise capacity impairment in individuals with neurofibromatosis type 1

American Journal of Medical Genetics, Part A

Volumn 161, Issue 2, 2013, Pages 393-395

  De Souza, Juliana Ferreira ^a   Araújo, Christiano Gonçalves ^a   de Rezende, Nilton Alves ^a   Rodrigues, Luiz Oswaldo Carneiro ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC CAPACITY; ARTERIAL PRESSURE; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; EXERCISE TEST; EXERCISE TOLERANCE; HEALTH STATUS; HEART MUSCLE FIBROSIS; HEART OUTPUT; HEART RATE; HUMAN; LETTER; LUNG GAS EXCHANGE; MUSCLE STRENGTH; MUSCLE TONE; MUSCULAR DYSTROPHY; NEUROFIBROMATOSIS; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TUMOR SUPPRESSOR GENE;

ADULT; ANAEROBIC THRESHOLD; CASE-CONTROL STUDIES; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; PILOT PROJECTS; YOUNG ADULT;

EID: 84872953780     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35729     Document Type: Letter

References (17)

1. Albouaini K, Egred M, Alahmar A, Wright DJ. 2007. Cardiopulmonary exercise testing and its applications. Heart 83:675-682.
2. ATS/ACCP Statement on Cardiopulmonary Exercise Testing. 2003. Am J Respir Care 167:211-277.
3. 2max decline with aging: An integrated perspective. Appl Physiol Nutr Metab 33:130-140.
4. Blair SN, Kohl HW, Arlow CE, Paffenbarger RS, Gibbons LW, Macera CA. 1995. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 273:1093-1098.
5. Bouchard C, Shepard RJ. 1994. Physical activity, fitness and health: The model and key concepts. In: Bouchard C, Shepard RJ, Stephens T, editors. Physical activity, fitness and health, International Proceedings and Consensus Statement. Champaign, IL: Human Kinetics. pp 77-88.
6. Bruce RA, Blackmon JR, Jones JW, Strait G. 1963. Exercising testing in adult normal subjects and cardiac patients. Pediatrics 32:742-756.
7. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. 2003. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381-1395.
8. Gobel FL, Nordstrom LA, Nelson RR, Jorgensen CR, Wang Y. 1978. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation 57:549-556.
9. Hutchinson P, Cureton K, Outz H, Wilson G. 1991. Relationship of cardiac size to maximal oxygen uptake and body size in men and women. Int J Sports Med 4:369-373.
10. Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A, Totsuka K, Shimano H, Ohashi Y, Yamada N, Sone H. 2009. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in health men and women-A meta-analysis. JAMA 301:2024-2035.
11. Kossler N, Stricker S, Rödelsperger C, Robinson PN, Kim J, Dietrich C, Osswald M, Kühnisch J, Stevenson DA, Braun T, Mundlos S, Kolanczyk M. 2011. Neurofibromin (nf1) is required for skeletal muscle development. Hum Mol Genet 20:2697-2709.
12. National Institute of Health (NIH). 1988. Consensus Development Conference. Neurofibromatosis. Arch Neurol 45:575-578.
13. Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb D, White L. 1999. Midlife hand grip strength as a predictor of old age disability. JAMA 281:558-560.
14. Siqueira FV, Facchini LA, Silveira DS, Piccini RX, Tomasi E, Halla PC. 2011. Leisure-time physical activity among adult and elderly individuals in Brazil: A countrywide analysis. J Phys Act Health 8:891-897.
15. Souza JF, Passos RLF, Guedes ACM, Rezende NA, Rodrigues LOC. 2009. Muscular force is reduced in neurofibromatosis type 1. J Musculoskelet Neuronal Interact 9:15-17.
16. Stevenson DA, Moyer-Mileur LJ, Carey JC, Quick JL, Hoff CJ, Viskochil DH. 2005. Case- control study of the muscular compartments and osseous strength in neurofibromatosis type 1 using peripheral quantitative computed tomography. J Musculoskeletal Neuronal Interact 5:145-149.
17. Wagner PD. 1996. Determinants of maximal oxygen transport and utilization. Annu Rev Physiol 58:21-50.